This report provides new information regarding comprehensive drug testing of clinical biological specimens collected after suspected opioid overdoses in various cities across the United States.
Patients presented to emergency departments within ACMT’s Toxicology Investigators Consortium (ToxIC) experiencing a suspected opioid overdose. Residual, discarded biological samples were obtained for testing against an expansive library of drugs and other substances. Our findings provide a near real-time assessment of the drug market and allude to resulting implications on clinical institutions.
Tags: 4-HO-DiPT 5F-MDMB-PICA Brorphine Butyrylfentanyl Clonazolam Etizolam Eutylone Fentanyl Flubromazolam Heroin MDMB-4en-PINACA Methadone New Drug Trends Opioid Crisis Para-fluorofentanyl PCP Tramadol Xylazine
